Squarepoint Ops LLC

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 1642575 NEW YORK, NY

Position in INO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$40,030

-$3,186 QoQ

Shares Held

36,391

+46.5% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#33

of 101 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. INO ranks #244 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	198,567	$123,814,467
2	BBIO	BridgeBio Pharma, Inc.	1,191,732	$88,760,199
3	ALNY	Alnylam Pharmaceuticals, Inc.	233,999	$70,440,718
4	INSM	INSMED Inc	616,464	$65,727,391
5	ARGX	Argenx SE	58,400	$54,181,768
6	RYTM	Rhythm Pharmaceuticals, Inc.	422,921	$46,956,918
7	APGE	Apogee Therapeutics, Inc.	290,713	$38,586,336
8	AXSM	Axsome Therapeutics, Inc.	154,605	$37,842,665

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$40,030	36,391	+46.5%	Shares	Defined	2026-08-14
2026-03-31	$43,216	24,837	-23.7%	Shares	Defined	2026-05-15
2025-06-30	$66,446	32,572	-36.5%	Shares	Defined	2025-08-27
2024-12-31	$93,796	51,255	-0.5%	Shares	Defined	2025-02-14
2024-09-30	$297,831	51,528	+137.2%	Shares	Defined	2024-11-14
2024-03-31	$301,487	21,721	+4.4%	Shares	Defined	2024-05-15
2023-06-30	$9,360	20,802	-57.2%	Shares	Defined	2023-08-14
2022-06-30	$84,091	48,608	+77.2%	Shares	Defined	2022-08-15
2021-09-30	$196,420	27,433	-67.7%	Shares	Defined	2021-11-15
2021-06-30	$786,438	84,837	+2.3%	Shares	Defined	2021-08-16
2020-12-31	$733,806	82,916	+189.9%	Shares	Defined	2021-02-16
2020-09-30	$331,748	28,599	-10.9%	Shares	Defined	2020-11-16
2020-06-30	$864,933	32,094	-7.8%	Shares	Defined	2020-08-14
2020-03-31	$258,964	34,807	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.